- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
OliX Pharmaceuticals Inc (226950)
OliX Pharmaceuticals Inc stock price live, this page displays KQ 226950 stock exchange data. View the 226950 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the OliX Pharmaceuticals Inc real time stock price chart below.
What Is the OliX Pharmaceuticals Inc Stock Price Today?
The OliX Pharmaceuticals Inc stock price today is 91,700.
What Is the Stock Symbol for OliX Pharmaceuticals Inc?
The stock symbol for OliX Pharmaceuticals Inc is ""226950.""
What Stock Exchange Does OliX Pharmaceuticals Inc Trade On?
OliX Pharmaceuticals Inc is listed and trades on the KOSDAQ stock exchange.
Is OliX Pharmaceuticals Inc a Good Stock to Buy?
Determining whether OliX Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 226950 quote. (ISIN: KR7226950004)
What Is the OliX Pharmaceuticals Inc Stock Price Today?
The OliX Pharmaceuticals Inc stock price today is 91,700.
What Is the Stock Symbol for OliX Pharmaceuticals Inc?
The stock symbol for OliX Pharmaceuticals Inc is ""226950.""
What Stock Exchange Does OliX Pharmaceuticals Inc Trade On?
OliX Pharmaceuticals Inc is listed and trades on the KOSDAQ stock exchange.
Is OliX Pharmaceuticals Inc a Good Stock to Buy?
Determining whether OliX Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 226950 quote. (ISIN: KR7226950004)
KOSDAQ
Currency in KRW
91,700
-2,100(-2.24%)
Closed·
Fair Value
An estimate of a OliX Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
88,200
95,500
52 wk Range
13,380
107,500
226950 Scorecard
Full Analysis
Stock generally trades with high price volatility
226950 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a OliX Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
88,20095,500
52 wk Range
13,380107,500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
226950 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a OliX Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Biotechnology industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
OliX Pharmaceuticals Inc Company Profile
OliX Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases. The company’s products pipeline includes OLX101A for skin scar; OLX104C for androgenic alopecia; OLX301A for age-related macular degeneration; OLX702A for metabolic dysfunction-associated steatohepatitis; OLX703A for hepatitis; and OLX301D for subretinal fibrosis. The company has a license and collaboration agreement with Hansoh Pharmaceuticals; development collaboration with Korea Institute of Technology; and research collaboration with the University of Virginia. The company was formerly known as Biomolecular Therapeutics Inc. OliX Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Suwon-si, South Korea.
Compare 226950 to Peers and Sector
Metrics to compare | 226950 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship226950PeersSector | |
|---|---|---|---|---|
P/E Ratio | −40.9x | −7.4x | −0.6x | |
PEG Ratio | 0.41 | −0.10 | 0.00 | |
Price/Book | 81.2x | 3.0x | 2.6x | |
Price / LTM Sales | 244.7x | 10.8x | 3.4x | |
Upside (Analyst Target) | - | 61.0% | 36.8% | |
Fair Value Upside | Unlock | 14.7% | 3.7% | Unlock |
Earnings
Latest Release
Aug 14, 2025
EPS / Forecast
-465.00 / --
Revenue / Forecast
6.25B / --
People Also Watch
FAQ
What Stock Exchange Does OliX Pharmaceuticals Trade On?
OliX Pharmaceuticals is listed and trades on the KOSDAQ stock exchange.
What Is the Stock Symbol for OliX Pharmaceuticals?
The stock symbol for OliX Pharmaceuticals is "226950."
What Is the OliX Pharmaceuticals Market Cap?
As of today, OliX Pharmaceuticals market cap is 1.84T.
What Is OliX Pharmaceuticals's Earnings Per Share (TTM)?
The OliX Pharmaceuticals EPS (TTM) is -2,478.00.
From a Technical Analysis Perspective, Is 226950 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has OliX Pharmaceuticals Stock Split?
OliX Pharmaceuticals has split 1 times.
How Many Employees Does OliX Pharmaceuticals Have?
OliX Pharmaceuticals has 0 employees.
What is the current trading status of OliX Pharmaceuticals (226950)?
As of 03 Oct 2025, OliX Pharmaceuticals (226950) is trading at a price of 91,700, with a previous close of 93,800.00. The stock has fluctuated within a day range of 88,200 to 95,500, while its 52-week range spans from 13,380 to 107,500.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.